CoolSpools
AutomatedIBM i (AS400) spooled file conversion software suite for converting reports and data to PDF, Excel, XML, and email formats.
CoolSpools has 5 plans: paid plans from $660. We have not recorded a price change.
CoolSpools plans and prices
CoolSpools Suite
one time$5,080
$5080 per LPAR
- one-time$5,080 one-time($5080 per LPAR)
- monthly$5,080/mo($5080 per LPAR)
- CoolSpools Converter
- CoolSpools Database
- CoolSpools Email
- CoolSpools Admin included free
- Free maintenance first year
- Annual maintenance $805 from year two
CoolSpools Converter
one time$3,010
$3010 per LPAR
- one-time$3,010 one-time($3010 per LPAR)
- monthly$3,010/mo($3010 per LPAR)
- Convert IBM i spooled files to PDF, Excel, XML, HTML, text, RTF, TIFF etc.
- Merge PDFs
- Easy to use flexible functions to enhance the converted output
- Free 30-day evaluation available
CoolSpools Database
one time$1,415
$1415 per LPAR
- one-time$1,415 one-time($1415 per LPAR)
- monthly$1,415/mo($1415 per LPAR)
- Convert IBM i database files to Excel, XML, HTML, Text, CSV
- Save query output and SQL selection results in any of those formats
- Import from Excel to a database file
- Validate an XML document against an XSD schema
- Free 30-day evaluation available
CoolSpools Email
one time$660
$660 per LPAR
- one-time$660 one-time($660 per LPAR)
- monthly$660/mo($660 per LPAR)
- Send emails with multiple attachments from your AS400
- Supports the entire IFS (not just QDLS), multiple attachments, and long file names
- Quickly, conveniently, and cost-effectively distribute reports and documents as email attachments
- Free 30-day evaluation available
CoolSpools Admin
monthly$730/mo
$730 per LPAR
- Get complete control over your IBM i (AS400) spool file data
- Automate the conversion and distribution of spool files
- Free 30-day evaluation available
Price history
Last 1 recorded changes
| Date | Plan | Change | Old | New | Δ% |
|---|---|---|---|---|---|
| Jul 26, 2026 | CoolSpools Admin | New plan | — | $730 | — |
Other Data Engineering products
No confirmed alternatives yet.